Vaccinex (VCNX) Institutional Ownership $1.00 +0.48 (+93.95%) As of 08/22/2025 02:55 PM Eastern Add Compare Share Share Ownership Stock AnalysisChartCompetitorsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Vaccinex (NASDAQ:VCNX)CurrentInstitutional OwnershipPercentage50.11%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$168.14KNumber ofInstitutional Sellers(last 12 months)0 Get VCNX Insider Trade Alerts Want to know when executives and insiders are buying or selling Vaccinex stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data VCNX Institutional Buying and Selling by Quarter Vaccinex Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024 Point72 Asset Management L.P.166,000$564K0.0%+42.4%9.595% 8/15/2024 Armistice Capital LLC94,000$610K0.0%-35.2%5.934% 8/7/2024 AIGH Capital Management LLC108,958$707K0.2%+86.7%6.896% 2/12/2024 AIGH Capital Management LLC817,061$543K0.2%-25.1%6.542% 2/9/2024 Worth Venture Partners LLC654,079$435K0.2%-8.8%5.237% 11/15/2023 Worth Venture Partners LLC717,559$811K0.5%+417.0%16.308% 11/15/2023 Armistice Capital LLC680,000$768K0.0%N/A15.455% 11/13/2023 AIGH Capital Management LLC1,090,173$1.23M0.6%-19.4%24.777% 5/15/2023 AIGH Capital Management LLC951,801$380K0.1%-61.2%1.735% 5/1/2023 Virtu Financial LLC103,898$42K0.0%N/A0.189% 2/16/2023 AIGH Capital Management LLC2,451,801$1.66M0.5%+17.8%4.915% 5/12/2022 AIGH Capital Management LLC2,081,801$2.63M0.6%N/A4.880% 11/16/2021Telemetry Investments L.L.C.132,500$286K0.4%+10.4%0.430% 11/15/2021 Natixis31,895$69K0.0%N/A0.104% 11/12/2021 Oppenheimer & Co. Inc.31,751$69K0.0%-24.3%0.103% 9/17/2021 Virtu Financial LLC38,026$106K0.0%+103.9%0.123% 8/16/2021 Point72 Asset Management L.P.395,522$1.11M0.0%N/A1.390% 8/16/2021Telemetry Investments L.L.C.120,000$336K0.5%+14.3%0.422% 8/16/2021 State Street Corp67,200$188K0.0%N/A0.236% 8/13/2021 Geode Capital Management LLC104,114$291K0.0%+59.4%0.366% 8/13/2021 Vanguard Group Inc.600,624$1.68M0.0%+145.9%2.111% (Data available from 1/1/2016 forward) VCNX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VCNX shares? During the previous two years, the following institutional investors and hedge funds held shares of Vaccinex shares: AIGH Capital Management LLC ($707K), Armistice Capital LLC ($610K), and Point72 Asset Management L.P. ($564K), Worth Venture Partners LLC ($435K).Learn more on Vaccinex's institutional investors. What percentage of Vaccinex's stock is owned by institutional investors? 50.11% of Vaccinex's stock is owned by institutional investors. Learn more on VCNX's institutional investor holdings. Which institutional investors have been buying Vaccinex's stock? The following institutional investors have purchased Vaccinex's stock in the last 24 months: Armistice Capital LLC ($680K), Worth Venture Partners LLC ($578.76K), AIGH Capital Management LLC ($50.59K), and Point72 Asset Management L.P. ($49.45K). How much institutional buying is happening at Vaccinex? Institutional investors have bought a total of 49,454 shares in the last 24 months. This purchase volume represents approximately $168.14K in transactions. Related Companies CYCN Institutional Ownership ACXP Institutional Ownership PRTG Institutional Ownership RNAZ Institutional Ownership BMRA Institutional Ownership TRAW Institutional Ownership KZIA Institutional Ownership BCLI Institutional Ownership MBIO Institutional Ownership PMCB Institutional Ownership This page (NASDAQ:VCNX) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccinex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccinex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access